Filing Details
- Accession Number:
- 0001415889-25-005067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-21 16:20:19
- Reporting Period:
- 2025-02-19
- Filing Date:
- 2025-02-21
- Accepted Time:
- 2025-02-21 16:20:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1810182 | Alx Oncology Holdings Inc | ALXO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1688269 | Jason Lettmann | C/O Alx Oncology Holdings Inc. 323 Allerton Avenue South San Francisco CA 94080 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-19 | 2,159 | $1.15 | 170,270 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2024.
Billionaire Hedge Funds
